Semaglutide PK in Chinese Subjects | Phase 1 Trial
A phase 1 RCT assessed semaglutide pharmacokinetics in healthy Chinese subjects, finding dose-proportional exposure consistent with global populations.
A phase 1 RCT assessed semaglutide pharmacokinetics in healthy Chinese subjects, finding dose-proportional exposure consistent with global populations.